Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma

  • Gang Peng (彭 纲)
  • Yang Ke (柯 杨)
  • Tao Wang (王 涛)
  • Yiming Feng (冯一鸣)
  • Yuehua Li (李跃华)
  • Gang Wu (伍 钢)Email author


Surgical excision and postoperative radiotherapy are widely accepted therapeutic modalities for sinonasal teratocarcinosarcoma (SNTCS). Previous studies have shown that intensity-modulated radiation therapy (IMRT) is safe and effective for the treatment of some sinonasal malignancies. We hypothesize that use of IMRT for SNTCS may result in clinical benefits. We report here two cases of SNTCS that were treated by IMRT. One patient was given extensive IMRT involving elective neck irradiation. Follow-up examinations revealed no recurrence and metastasis 3.5 years after IMRT. Another patient simultaneously suffered from multiple systematical diseases and was administered involved-field radiotherapy. He was found to have a marginal recurrence during the follow up and eventually died 8 months after disease diagnosis. It was suggested in this study that appropriate use of IMRT for the treatment of SNTCS may achieve excellent local control.

Key words

sinonasal teratocarcinosarcoma radiotherapy head and neck cancer intensity-modulated radiation therapy paranasal sinus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wei S, Carroll W, Lazenby A, et al. Sinonasal teratocarcinosarcoma: report of a case with review of literature and treatment outcome. Ann diagn pathol, 2008,12(6): 415–425PubMedCrossRefGoogle Scholar
  2. 2.
    Budrukkar A, Agarwal JP, Kane S, et al. Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. J laryngol otol, 2010,124(7): 739–743PubMedCrossRefGoogle Scholar
  3. 3.
    Smith SL, Hessel AC, Luna MA, et al. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch otolaryngol head & neck surg, 2008,134(6):592–595CrossRefGoogle Scholar
  4. 4.
    Heffner DK, Hyams VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses A clinicopathologic study of 20 cases. Cancer, 1984,53(10):2140–2154PubMedCrossRefGoogle Scholar
  5. 5.
    Sharma HS, Abdullah JM, Othman NH, et al. Teratocarcinosarcoma of the nasal cavity and ethmoid. J laryngolotol, 1998,112(7): 682–686Google Scholar
  6. 6.
    Takasaki K, Sakihama N, Takahashi H. A case with sinonasal teratocarcinosarcoma in the nasal cavity and ethmoid sinus. Eur Arch Otorhinolaryngol, 2006,263(6): 586–591PubMedCrossRefGoogle Scholar
  7. 7.
    Parsons JT, Mendenhall WM, Mancuso AA, et al. Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses. Int J Radiat Oncol Biol Phys, 1988,14(1): 11–22PubMedCrossRefGoogle Scholar
  8. 8.
    Daly ME, Chen AM, Bucci MK, et al. Intensitymodulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys, 2007,67(1):151–157PubMedCrossRefGoogle Scholar
  9. 9.
    Lai SZ, Li WF, Chen L, et al. How does intensitymodulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys, 2011,80(3):661–668PubMedCrossRefGoogle Scholar
  10. 10.
    Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol, 2005,74(3):251–258PubMedCrossRefGoogle Scholar
  11. 11.
    Madani I, Bonte K, Vakaet L, et al. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys, 2009,73(2):424–432PubMedCrossRefGoogle Scholar
  12. 12.
    Shanmugaratnam K, Kunaratnam N, Chia KB, et al. Teratoid carcinosarcoma of the paranasal sinuses. Pathology, 1983,15(4):413–419PubMedCrossRefGoogle Scholar
  13. 13.
    Carrizo F, Pineda-Daboin K, Neto AG, et al. Pharyngeal teratocarcinosarcoma: review of the literature and report of two cases. Ann diagn pathol, 2006,10(6):339–342PubMedCrossRefGoogle Scholar
  14. 14.
    Rotenberg B, El-Hakim H, Lodha A, et al. Nasopharyngeal teratocarcinosarcoma. Int J Pediatr Otorhinolaryngol, 2002,62(2):159–164PubMedCrossRefGoogle Scholar
  15. 15.
    Endo H, Hirose T, Kuwamura KI, et al. Case report: Sinonasal teratocarcinosarcoma. Pathol Intern, 2001,51(2): 107–112CrossRefGoogle Scholar
  16. 16.
    Ogawa T, Ikeda K, Watanabe M, et al. A case report of sinonasal teratocarcinosarcoma. Tohoku J Exp Med, 2000, 190(1):51–59PubMedCrossRefGoogle Scholar
  17. 17.
    Chao KK, Eng TY, Barnes J, et al. Sinonasal teratocarcinosarcoma. Am J Clin Oncol, 2004,27(1):29–32PubMedCrossRefGoogle Scholar
  18. 18.
    Pai SA, Naresh KN, Masih K, et al. Teratocarcinosarcoma of the paranasal sinuses: a clinicopathologic and immunohistochemical study. Human pathology, 1998, 29(7):718–722PubMedCrossRefGoogle Scholar
  19. 19.
    Batsakis JG, el-Naggar AK, Luna MA. Teratomas of the head and neck with emphasis on malignancy. Ann Otol Rhinol Laryngol, 1995,104(6):496–500PubMedGoogle Scholar
  20. 20.
    Duthoy W, Boterberg T, Claus F, et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer, 2005,104(1):71–82PubMedCrossRefGoogle Scholar
  21. 21.
    Claus F, Mijnheer B, Rasch C, et al. Report of a study on IMRT planning strategies for ethmoid sinus cancer. Strahlenther Onkol, 2002,178(10):572–576PubMedCrossRefGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Gang Peng (彭 纲)
    • 1
  • Yang Ke (柯 杨)
    • 1
  • Tao Wang (王 涛)
    • 1
  • Yiming Feng (冯一鸣)
    • 1
  • Yuehua Li (李跃华)
    • 1
  • Gang Wu (伍 钢)
    • 1
    Email author
  1. 1.Cancer Center, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations